Association of the vitamin D receptor gene start codon Fok I polymorphism with calcium oxalate stone disease

被引:35
作者
Chen, WC
Chen, HY
Lu, HF
Hsu, CD
Tsai, FJ
机构
[1] China Med Coll Hosp, Sch Med, Dept Urol, Taichung, Taiwan
[2] China Med Coll Hosp, Sch Med, Dept Obstet & Gynecol, Taichung, Taiwan
[3] China Med Coll Hosp, Sch Med, Dept Med Genet, Taichung, Taiwan
[4] Natl Tsing Hua Univ, Inst Life Sci, Hsinchu, Taiwan
关键词
vitamin D receptor polymorphism; urolithiasis; single nucleotide polymorphisms;
D O I
10.1046/j.1464-410x.2001.02074.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objective To assess the use of Fok I polymorphism (the most frequent polymorphism, at the start codon of the vitamin D receptor gene, VDR) as a convenient genetic marker in identifying the cause of urolithiasis. Patients, subjects and methods A normal control group of 90 healthy subjects and 146 patients with calcium oxalate stones were examined. Using polymerase chain reaction (PCR)-based restriction analysis, the relationship between Fok I polymorphism and urolithiasis was evaluated. An unexcisable length of 265 bp was identified (allele CC) and two fragments (169 bp and 96 bp) identified as excisable lengths (allele TT). Results There was a statistically significant difference between the groups (chi-square test, P < 0.05) for the genotype of the VDR Fok I start codon polymorphism. The odds ratio (95% confidence interval) for the C allele in those at risk of stone disease was 1.672 (1.149-2.432). Conclusions These results suggest that the VDR Fok I start codon polymorphism may be a good candidate for a genetic marker in calcium oxalate stone disease.
引用
收藏
页码:168 / 171
页数:4
相关论文
共 20 条
[1]   ISOLATION OF THE HUMAN-GENE FOR BONE GLA PROTEIN UTILIZING MOUSE AND RAT CDNA CLONES [J].
CELESTE, AJ ;
ROSEN, V ;
BUECKER, JL ;
KRIZ, R ;
WANG, EA ;
WOZNEY, JM .
EMBO JOURNAL, 1986, 5 (08) :1885-1890
[2]   Diet and calcium: The end of an era? [J].
Coe, FL ;
Parks, JH ;
Favus, MJ .
ANNALS OF INTERNAL MEDICINE, 1997, 126 (07) :553-555
[3]   MEDICAL PROGRESS - THE PATHOGENESIS AND TREATMENT OF KIDNEY-STONES [J].
COE, FL ;
PARKS, JH ;
ASPLIN, JR .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (16) :1141-1152
[4]   A PROSPECTIVE-STUDY OF DIETARY CALCIUM AND OTHER NUTRIENTS AND THE RISK OF SYMPTOMATIC KIDNEY-STONES [J].
CURHAN, GC ;
WILLETT, WC ;
RIMM, EB ;
STAMPFER, MJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (12) :833-838
[5]   Genetic disorders and urolithiasis [J].
Danpure, CJ .
UROLOGIC CLINICS OF NORTH AMERICA, 2000, 27 (02) :287-+
[6]   Genes in idiopathic calcium oxalate stone disease [J].
Goodman, HO ;
Brommage, R ;
Assimos, DG ;
Holmes, RP .
WORLD JOURNAL OF UROLOGY, 1997, 15 (03) :186-194
[7]  
Gross C, 1996, J BONE MINER RES, V11, P1850
[8]   The vitamin D receptor start codon polymorphism (FokI) and bone mineral density in premenopausal American black and white women [J].
Harris, SS ;
Eccleshall, TR ;
Gross, C ;
DawsonHughes, B ;
Feldman, D .
JOURNAL OF BONE AND MINERAL RESEARCH, 1997, 12 (07) :1043-1048
[9]   Familial calcium stone disease:: TaqI polymorphism and the vitamin D receptor [J].
Jackman, SV ;
Kibel, AS ;
Ovuworie, CA ;
Moore, RG ;
Kavoussi, LR ;
Jarrett, TW .
JOURNAL OF ENDOUROLOGY, 1999, 13 (04) :313-316
[10]   ACTIVATION OF PROTEIN-KINASE-C INHIBITS VITAMIN-D RECEPTOR GENE-EXPRESSION [J].
KRISHNAN, AV ;
FELDMAN, D .
MOLECULAR ENDOCRINOLOGY, 1991, 5 (04) :605-612